Caiyun Liao1, Dongyu Zhang1, Chemtai Mungo1, D Andrew Tompkins2, Amer M Zeidan3. 1. The Johns Hopkins University Bloomberg School of Public Health, 615 N. Wolfe Street, Baltimore, MD 21205, USA. 2. Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine Behavioral Pharmacology Research Unit, 5510 Nathan Shock Drive, Baltimore, MD 21224, USA. 3. Section of Hematology, Department of Internal Medicine, Yale University, and Yale Cancer Center, New Haven, CT, USA. Electronic address: amer.zeidan@yale.edu.
Abstract
OBJECTIVE: To assess the association between diabetes mellitus (DM) and the incidence and disease-specific mortality of endometrial cancer (EC). METHODS: MEDLINE, EMBASE and conference abstracts of the 2011-2013 Annual Meetings of Society of Gynecological Oncology were searched for reports of original cohort studies that enrolled diabetic and non-diabetic women who were free of EC at baseline to compare the incidence and disease-specific mortality of EC by DM status. The included reports were examined for demographic characteristics of study populations, study design, effect measures and risk of bias. Statistical heterogeneity was evaluated with Chi-square test of the Cochrane Q statistics at the 0.05 significance level and I(2) statistic. Publication bias was assessed by visual examination of a funnel plot and the Egger's test for small-study effects. RESULTS: Twenty-nine cohort studies (17 prospective, 12 retrospective) were eligible for this review, 23 of which reported EC incidence, five reported disease-specific mortality and one reported both. For incidence of EC among women with versus without DM, the summary relative risk (RR) was 1.89 (95%CI, 1.46-2.45; p<0.001) and the summary incidence rate ratio was 1.61 (95%CI, 1.51-1.71; p<0.001). The pooled RR of disease-specific mortality was 1.32 (95%CI, 1.10-1.60; p=0.003), while results in the studies reporting standardized mortality ratios were inconsistent. There remains considerable amount of clinical and methodological heterogeneity among the included studies; moreover, the hazard ratios for incident EC showed significant statistical heterogeneity and therefore were not quantitatively synthesized. CONCLUSIONS: There is consistent evidence for an independent association between DM and an increased risk of incident EC, while the association between DM and EC-specific mortality remains uncertain. Further studies with better considerations for selection bias, information bias and confounding will further facilitate causal inference involving DM and EC.
OBJECTIVE: To assess the association between diabetes mellitus (DM) and the incidence and disease-specific mortality of endometrial cancer (EC). METHODS: MEDLINE, EMBASE and conference abstracts of the 2011-2013 Annual Meetings of Society of Gynecological Oncology were searched for reports of original cohort studies that enrolled diabetic and non-diabeticwomen who were free of EC at baseline to compare the incidence and disease-specific mortality of EC by DM status. The included reports were examined for demographic characteristics of study populations, study design, effect measures and risk of bias. Statistical heterogeneity was evaluated with Chi-square test of the Cochrane Q statistics at the 0.05 significance level and I(2) statistic. Publication bias was assessed by visual examination of a funnel plot and the Egger's test for small-study effects. RESULTS: Twenty-nine cohort studies (17 prospective, 12 retrospective) were eligible for this review, 23 of which reported EC incidence, five reported disease-specific mortality and one reported both. For incidence of EC among women with versus without DM, the summary relative risk (RR) was 1.89 (95%CI, 1.46-2.45; p<0.001) and the summary incidence rate ratio was 1.61 (95%CI, 1.51-1.71; p<0.001). The pooled RR of disease-specific mortality was 1.32 (95%CI, 1.10-1.60; p=0.003), while results in the studies reporting standardized mortality ratios were inconsistent. There remains considerable amount of clinical and methodological heterogeneity among the included studies; moreover, the hazard ratios for incident EC showed significant statistical heterogeneity and therefore were not quantitatively synthesized. CONCLUSIONS: There is consistent evidence for an independent association between DM and an increased risk of incident EC, while the association between DM and EC-specific mortality remains uncertain. Further studies with better considerations for selection bias, information bias and confounding will further facilitate causal inference involving DM and EC.
Authors: X H Zhou; Q Qiao; B Zethelius; K Pyörälä; S Söderberg; A Pajak; C D A Stehouwer; R J Heine; P Jousilahti; G Ruotolo; P M Nilsson; G Calori; J Tuomilehto Journal: Diabetologia Date: 2010-05-21 Impact factor: 10.122
Authors: Steven S Coughlin; Eugenia E Calle; Lauren R Teras; Jennifer Petrelli; Michael J Thun Journal: Am J Epidemiol Date: 2004-06-15 Impact factor: 4.897
Authors: Seungmin Kim; Jihye Park; Yuji Chen; Kerry Rowe; John Snyder; Alison Fraser; Ken Smith; Vikrant G Deshmukh; Michael Newman; Kimberley Herget; Christina A Porucznik; Dominik Ose; Mary Playdon; David Gaffney; Mia Hashibe Journal: Gynecol Oncol Date: 2019-12-12 Impact factor: 5.482
Authors: Todd R Sponholtz; Julie R Palmer; Lynn Rosenberg; Elizabeth E Hatch; Lucile L Adams-Campbell; Lauren A Wise Journal: Am J Epidemiol Date: 2016-01-27 Impact factor: 4.897
Authors: R Troisi; T Bjørge; M Gissler; T Grotmol; C M Kitahara; S M Myrtveit Saether; A G Ording; C Sköld; H T Sørensen; B Trabert; I Glimelius Journal: J Intern Med Date: 2018-03-25 Impact factor: 8.989
Authors: Elina Urpilainen; Anne Ahtikoski; Reetta Arima; Ulla Puistola; Peeter Karihtala Journal: Front Pharmacol Date: 2021-05-13 Impact factor: 5.810
Authors: Maxine M Chen; Tracy A O'Mara; Deborah J Thompson; Jodie N Painter; John Attia; Amanda Black; Louise Brinton; Stephen Chanock; Chu Chen; Timothy Ht Cheng; Linda S Cook; Marta Crous-Bou; Jennifer Doherty; Christine M Friedenreich; Montserrat Garcia-Closas; Mia M Gaudet; Maggie Gorman; Christopher Haiman; Susan E Hankinson; Patricia Hartge; Brian E Henderson; Shirley Hodgson; Elizabeth G Holliday; Pamela L Horn-Ross; David J Hunter; Loic Le Marchand; Xiaolin Liang; Jolanta Lissowska; Jirong Long; Lingeng Lu; Anthony M Magliocco; Lynn Martin; Mark McEvoy; Sara H Olson; Irene Orlow; Loreall Pooler; Jennifer Prescott; Radhai Rastogi; Timothy R Rebbeck; Harvey Risch; Carlotta Sacerdote; Frederick Schumacher; Veronica Wendy Setiawan; Rodney J Scott; Xin Sheng; Xiao-Ou Shu; Constance Turman; David Van Den Berg; Zhaoming Wang; Noel S Weiss; Nicholas Wentzensen; Lucy Xia; Yong-Bing Xiang; Hannah P Yang; Herbert Yu; Wei Zheng; Paul D P Pharoah; Alison M Dunning; Ian Tomlinson; Douglas F Easton; Peter Kraft; Amanda B Spurdle; Immaculata De Vivo Journal: Hum Mol Genet Date: 2016-03-23 Impact factor: 6.150